表紙
市場調查報告書

病毒學、細菌學的全球市場:各技術、疾病、終端用戶、地區、競爭、預測及機會(2025年)

Global Virology and Bacteriology Market, By Technology, By Disease, By End User, By Region, Competition, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 953899
出版日期 內容資訊 英文 126 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

病毒學、細菌學的全球市場:各技術、疾病、終端用戶、地區、競爭、預測及機會(2025年) Global Virology and Bacteriology Market, By Technology, By Disease, By End User, By Region, Competition, Forecast & Opportunities, 2025
出版日期: 2020年08月01日內容資訊: 英文 126 Pages
簡介

全球病毒學、細菌學市場,預計從2021年到2025年之間以約12%的年複合成長率成長。 由於受病毒及細菌感染影響的人口增加而推動該市場的成長。再加上全球各政府對醫療保健基礎設施的進一步投資,給予市場成長積極的影響。還有研究開發活動的持續性技術創新,預計更加強化今後數年的市場成長。

本報告提供全球病毒學、細菌學市場的相關調查,市場規模、預測,佔有率和趨勢,成長要素,各技術、疾病、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 COVID-19的影響

第4章 摘要整理

第5章 VOC (客戶的迴響)

第6章 市場展望

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各技術(分子診斷,免疫測量,影像診斷,資訊技術)
    • 各疾病(呼吸系統,尿路,及血流疾病,腸胃疾病、牙周疾病,性感染疾病)
    • 各終端用戶(診所,醫院,診斷中心,研究,血液銀行)
    • 各企業(2019)
    • 各地區
  • 市場魅力指數

第7章 亞太地區

第8章 歐洲

第9章 北美

第10章 南美

第11章 中東、非洲

第12章 市場動態

  • 成長要素
  • 課題

第13章 市場趨勢

第14章 專利分析

第15章 競爭情形

  • FUJIREBIO株式會社
  • Cepheid Inc.
  • DiaSorin S.p.A.
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Scienion AG
  • Grifols S.A.
  • Qiagen N.V.
  • 榮研化學株式會社
  • Sequenom Inc.
  • bioMerieux SA
  • Siemens AG
  • Hologic Inc.
  • Diamedix Corporation
  • Leica Biosystems Nussloch GmbH
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • GSK Biologicals SA

第16章 策略性建議

目錄
Product Code: 4700

Title:
Global Virology and Bacteriology Market, By Technology (Molecular Diagnostics, Immunoassays, Diagnostic Imaging, Information Technology), By Disease (Respiratory System, Urinary Tract, And Bloodstream Diseases, Gastrointestinal, Sexually Transmitted Diseases), By End User (Clinics, Hospitals, Diagnostic Centers, Research Laboratories, And Blood Banks), By Region, Competition, Forecast & Opportunities, 2025.

Global virology and bacteriology market is expected to grow at a CAGR of around 12% during 2021 - 2025. The global virology and bacteriology market is driven by rising population getting affected by viral and bacterial infections. Moreover, governments across the globe are investing more on healthcare infrastructure, which is positively impacting the market growth. Also, continuous technological innovations in research and development activities is further expected to bolster the growth of market over the next few years.

The global virology and bacteriology market is segmented based on technology, disease, end user, company, and region. Based on technology, the market can be categorized into molecular diagnostics, immunoassays, diagnostic imaging, and information technology. Out of these, the molecular diagnostics segment dominated the market in 2019 and is expected to maintain its leading position during the forecast period as well. This can be ascribed to the fact that this technology allows the detection of lower amount of infectious agents, thereby detecting the infection at an early stage than was previously possible.

Major players operating in the global virology and bacteriology market include Fujirebio Diagnostics Inc., Cepheid Inc., DiaSorin S.p.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Scienion AG, Grifols S.A., Qiagen N.V., Eiken Chemical Co Ltd, Sequenom Inc., bioMerieux SA, Siemens AG, Hologic Inc., Diamedix Corporation, Leica Biosystems Nussloch GmbH, F. Hoffmann-La Roche AG, Abbott Laboratories, GSK Biologicals SA among others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers, acquisitions, collaborations and partnerships.

Years considered for this report:

Historical Years: 2015 - 2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021 - 2025

Objective of the Study:

  • To analyze and estimate the market size of global virology and bacteriology market from 2015 to 2018.
  • To estimate and forecast the market size of global virology and bacteriology market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global virology and bacteriology market based on technology, disease, end user, company and regional distribution.
  • To identify dominant region or segment in the global virology and bacteriology market.
  • To identify drivers and challenges for global virology and bacteriology market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global virology and bacteriology market.
  • To identify and analyze the profile of leading players operating in global virology and bacteriology market.
  • To identify key sustainable strategies adopted by market players in global virology and bacteriology market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of market players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across the globe.

TechSci Research calculated the market size of global virology and bacteriology market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Virology and bacteriology hospitals/clinics, laboratories and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to virology and bacteriology market
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global virology and bacteriology market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Technology:

Molecular Diagnostics

Immunoassays

Diagnostic Imaging

Information Technology

  • Market, By Disease:

Respiratory System

Urinary Tract, And Bloodstream Diseases

Gastrointestinal and Periodontal Diseases

Sexually Transmitted Diseases

  • Market, By Disease:

Clinics

Hospitals

Diagnostic Centers

Research Laboratories

Blood Banks

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global virology and bacteriology market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Virology and Bacteriology Market

4. Executive Summary

5. Voice of Customer

6. Global Virology and Bacteriology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology (Molecular Diagnostics, Immunoassays, Diagnostic Imaging, Information Technology)
    • 6.2.2. By Disease (Respiratory System, Urinary Tract, And Bloodstream Diseases; Gastrointestinal and Periodontal Diseases; Sexually Transmitted Diseases)
    • 6.2.3. By End User (Clinics, Hospitals, Diagnostic Centers, Research Laboratories, And Blood Banks)
    • 6.2.4. By Company (2019)
    • 6.2.5. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Virology and Bacteriology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Disease
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Virology and Bacteriology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Disease
        • 7.3.1.2.3. By End User
    • 7.3.2. India Virology and Bacteriology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Disease
        • 7.3.2.2.3. By End User
    • 7.3.3. Japan Virology and Bacteriology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Disease
        • 7.3.3.2.3. By End User
    • 7.3.4. South Korea Virology and Bacteriology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Disease
        • 7.3.4.2.3. By End User
    • 7.3.5. Australia Virology and Bacteriology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Disease
        • 7.3.5.2.3. By End User
    • 7.3.6. Singapore Virology and Bacteriology Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Technology
        • 7.3.6.2.2. By Disease
        • 7.3.6.2.3. By End User

8. Europe Virology and Bacteriology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Disease
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Virology and Bacteriology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Disease
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Virology and Bacteriology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Disease
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Virology and Bacteriology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Disease
        • 8.3.3.2.3. By End Use
    • 8.3.4. Italy Virology and Bacteriology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Disease
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Virology and Bacteriology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Disease
        • 8.3.5.2.3. By End User
    • 8.3.6. Russia Virology and Bacteriology Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Technology
        • 8.3.6.2.2. By Disease
        • 8.3.6.2.3. By End User

9. North America Virology and Bacteriology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Disease
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Virology and Bacteriology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Disease
        • 9.3.1.2.3. By End User
    • 9.3.2. Mexico Virology and Bacteriology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Disease
        • 9.3.2.2.3. By End User
    • 9.3.3. Canada Virology and Bacteriology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Disease
        • 9.3.3.2.3. By End User

10. South America Virology and Bacteriology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Disease
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Virology and Bacteriology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Disease
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Virology and Bacteriology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Disease
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Virology and Bacteriology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Disease
        • 10.3.3.2.3. By End Use

11. Middle East and Africa Virology and Bacteriology Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Technology
    • 11.2.2. By Disease
    • 11.2.3. By End User
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Virology and Bacteriology Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Technology
        • 11.3.1.2.2. By Disease
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Virology and Bacteriology Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Technology
        • 11.3.2.2.2. By Disease
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Virology and Bacteriology Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Technology
        • 11.3.3.2.2. By Disease
        • 11.3.3.2.3. By End User
    • 11.3.4. Kuwait Virology and Bacteriology Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Technology
        • 11.3.4.2.2. By Disease
        • 11.3.4.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Patent Analysis

15. Competitive Landscape

  • 15.1. Fujirebio Diagnostics Inc.
  • 15.2. Cepheid Inc.
  • 15.3. DiaSorin S.p.A.
  • 15.4. Bio-Rad Laboratories Inc.
  • 15.5. Thermo Fisher Scientific Inc.
  • 15.6. Scienion AG
  • 15.7. Grifols S.A.
  • 15.8. Qiagen N.V.
  • 15.9. Eiken Chemical Co. Ltd.
  • 15.10. Sequenom Inc.
  • 15.11. bioMerieux SA
  • 15.12. Siemens AG
  • 15.13. Hologic Inc.
  • 15.14. Diamedix Corporation
  • 15.15. Leica Biosystems Nussloch GmbH
  • 15.16. F. Hoffmann-La Roche AG
  • 15.17. Abbott Laboratories
  • 15.18. GSK Biologicals SA

16. Strategic Recommendations

List of Figures

  • Figure 1: Global Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 2: Global Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 3: Global Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 4: Global Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 5: Global Virology and Bacteriology Market Size, By Company (USD Million), 2015-2025F
  • Figure 6: Global Virology and Bacteriology Market Size, By Region (USD Million), 2015-2025F
  • Figure 7: Global Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 8: North America Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 9: North America Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 10: North America Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 11: North America Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 12: North America Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
  • Figure 13: North America Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 14: North America Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 15: United States Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 16: United States Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 17: United States Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 18: United States Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 19: United States Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 20: Canada Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 21: Canada Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 22: Canada Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 23: Canada Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 24: Canada Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 25: Mexico Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 26: Mexico Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 27: Mexico Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 28: Mexico Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 29: Mexico Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 30: Europe Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 31: Europe Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 32: Europe Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 33: Europe Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 34: Europe Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
  • Figure 35: Europe Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 36: Europe Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 37: France Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 38: France Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 39: France Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 40: France Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 41: France Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 42: Germany Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 43: Germany Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 44: Germany Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 45: Germany Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 46: Germany Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 47: Italy Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 48: Italy Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 49: Italy Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 50: Italy Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 51: Italy Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 52: Spain Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 53: Spain Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 54: Spain Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 55: Spain Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 56: Spain Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 57: United Kingdom Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 58: United Kingdom Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 59: United Kingdom Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 60: United Kingdom Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 61: United Kingdom Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 62: Russia Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 63: Russia Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 64: Russia Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 65: Russia Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 66: Russia Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 67: Asia-Pacific Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 68: Asia-Pacific Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 69: Asia-Pacific Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 70: Asia-Pacific Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 71: Asia-Pacific Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
  • Figure 72: Asia-Pacific Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 73: Asia-Pacific Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 74: China Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 75: China Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 76: China Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 77: China Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 78: China Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 79: India Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 80: India Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 81: India Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 82: India Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 83: India Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 84: Japan Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 85: Japan Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 86: Japan Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 87: Japan Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 88: Japan Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 89: South Korea Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 90: South Korea Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 91: South Korea Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 92: South Korea Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 93: South Korea Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 94: Australia Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 95: Australia Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 96: Australia Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 97: Australia Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 98: Australia Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 99: Singapore Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 100: Singapore Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 101: Singapore Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 102: Singapore Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 103: Singapore Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 104: Middle East and Africa Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 105: Middle East and Africa Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 106: Middle East and Africa Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 107: Middle East and Africa Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 108: Middle East and Africa Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
  • Figure 109: Middle East and Africa Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 110: Middle East and Africa Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 111: South Africa Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 112: South Africa Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 113: South Africa Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 114: South Africa Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 115: South Africa Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 116: Saudi Arabia Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 117: Saudi Arabia Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 118: Saudi Arabia Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 119: Saudi Arabia Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 120: Saudi Arabia Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 121: Kuwait Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 122: Kuwait Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 123: Kuwait Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 124: Kuwait Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 125: Kuwait Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 126: UAE Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 127: UAE Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 128: UAE Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 129: UAE Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 130: UAE Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 131: South America Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 132: South America Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 133: South America Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 134: South America Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 135: South America Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
  • Figure 136: South America Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 137: South America Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 138: Brazil Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 139: Brazil Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 140: Brazil Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 141: Brazil Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 142: Brazil Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 143: Argentina Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 144: Argentina Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 145: Argentina Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 146: Argentina Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 147: Argentina Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 148: Colombia Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 149: Colombia Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 150: Colombia Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 151: Colombia Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 152: Colombia Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F